Clinical factors and ABCB1 polymorphisms in prediction of antiepileptic drug response: a prospective cohort study
- 31 August 2006
- journal article
- research article
- Published by Elsevier BV in The Lancet Neurology
- Vol. 5 (8), 668-676
- https://doi.org/10.1016/s1474-4422(06)70500-2
Abstract
No abstract availableKeywords
This publication has 27 references indexed in Scilit:
- Complex Haplotypic Effects of the ABCB1 Gene on Epilepsy Treatment ResponsePharmacogenomics, 2005
- Drug Resistance in Epilepsy: Putative Neurobiologic and Clinical MechanismsEpilepsia, 2005
- Blood-brain barrier active efflux transporters: ATP-binding cassette gene familyNeuroRX, 2005
- Association of an ABCB1 gene haplotype with pharmacoresistance in temporal lobe epilepsyNeurology, 2004
- Expression and Cellular Distribution of Multidrug Resistance–related Proteins in the Hippocampus of Patients with Mesial Temporal Lobe EpilepsyEpilepsia, 2004
- P Glycoprotein in Human Immunodeficiency Virus Type 1 Infection and TherapyAntimicrobial Agents and Chemotherapy, 2004
- P-glycoprotein: from genomics to mechanismOncogene, 2003
- Association of Multidrug Resistance in Epilepsy with a Polymorphism in the Drug-Transporter GeneABCB1New England Journal of Medicine, 2003
- Overexpression of Multiple Drug Resistance Genes in Endothelial Cells from Patients with Refractory EpilepsyEpilepsia, 2001
- MDR1 Gene Expression in Brain of Patients with Medically Intractable EpilepsyEpilepsia, 1995